Newsletter

Philippines Medical Tourism: Accredited Hospitals, Competitive Costs & Rising Medical Device Demand – October/November 2026

Philippines Medical Tourism: Accredited Hospitals, Competitive Costs & Rising Medical Device Demand – October/November 2026

  • 2026-11-19 04:42:27

Ranked Southeast Asia's 3rd-largest medical tourism destination, the Philippines offers 6 JCI-accredited hospitals and treatment costs 40-80% lower than in Western countries. Cosmetic surgery, cardiology, and oncology lead patient demand, while fertility treatment grows fastest. With medical tourism projected to reach US$5B by 2034 and device imports up 15% in 2025, diagnostic imaging, cardiology, and dialysis devices show strong potential.

More
Indonesia: Guidelines for Marketing Authorization of Software-Based Medical Devices – October/November 2026

Indonesia: Guidelines for Marketing Authorization of Software-Based Medical Devices – October/November 2026

  • 2026-11-19 02:55:13

The Ministry of Health (MoH) of Indonesia has issued Minister of Health Decree No. HK.01.07/MENKES/951/2026 concerning Guidelines for Marketing Authorization of Software-Based Medical Devices, dated 7 September 2026. The decree establishes technical requirements and procedures for obtaining marketing authorization (Izin Edar) for software-based medical devices distributed in Indonesia. The new guidelines cover Software as a Medical Device (SaMD), Software in a Medical Device (SiMD), and medical devices incorporating Artificial Intelligence (AI) applications. They aim to ensure the safety, performance, and quality of software-based medical devices while addressing emerging regulatory considerations, including software lifecycle management, cybersecurity, clinical validation, and personal data protection.

More
Indonesia: Extends Halal Certification Deadlines and Revises Foreign Halal Product Regulations – October/November 2026

Indonesia: Extends Halal Certification Deadlines and Revises Foreign Halal Product Regulations – October/November 2026

  • 2026-11-19 02:33:53

The Indonesian Government has extended the phased implementation of mandatory halal certification to provide additional time for strengthening the halal ecosystem and improving the readiness of all relevant stakeholders. The deadlines have been adjusted for Class A medical device with the implementation period extending up to 17 October 2028. The Government has also amended the implementing provisions of Government Regulation No. 42 of 2024 through Government Regulation No. 40 of 2026, including changes to the provisions governing the halal conformity of foreign products entering Indonesia.

More
Singapore: HSA Medical Device Updates – Registration Guidance, Premarket Checklist and Concurrent Change Notifications – October/November 2026

Singapore: HSA Medical Device Updates – Registration Guidance, Premarket Checklist and Concurrent Change Notifications – October/November 2026

  • 2026-11-19 02:22:44

Singapore's Health Sciences Authority (HSA) announced several important medical device regulatory updates in September 2026, covering product registration guidance, premarket submission requirements and concurrent Change Notification (CN) applications.
These developments include revised product registration guidance documents, the introduction of a Premarket Submission Checklist and further clarification of concurrent CN procedures. Together, the updates aim to support more consistent regulatory submissions and improve the efficiency of medical device registration and post-registration change management in Singapore.

More
Japan: Voluntary Standards for Home-use Nitric Oxide (NO) Generating Devices for Blood Circulation Promotion – October/November 2026

Japan: Voluntary Standards for Home-use Nitric Oxide (NO) Generating Devices for Blood Circulation Promotion – October/November 2026

  • 2026-11-19 01:27:29

On November 5th, 2026, the Ministry of Health, Labour and Welfare (MHLW) announced a new Generic Name, "Home-use Nitric Oxide (NO) Generating Devices for Blood Circulation Promotion", together with a notice regarding its applicable voluntary standards. Manufacturers should refer to these documents to ensure that their devices meet the relevant definition and performance requirements. The corresponding verification reports are also expected to be included as part of the notification dossier.

More
Qualtech Webinar: Clinical Evidence Requirements and the Clinical Investigation Landscape to Access the European Market – November 2026

Qualtech Webinar: Clinical Evidence Requirements and the Clinical Investigation Landscape to Access the European Market – November 2026

  • 2026-11-09 04:27:21

Qualtech invites you to join our free webinar on Thursday, November 26, 2026, with the topic "Clinical Evidence Requirements and the Clinical Investigation Landscape to Access the European Market". In collaboration with Spain-based CRO Iberania, our invited regulatory expert and guest speaker will share practical insights into the clinical evidence requirements under the EU MDR and how to best conduct clinical investigations in Europe, so that successful market access and regulatory compliance can be ensured.

More
Australia's Type 1 Diabetes Market: Device Demand, Reimbursement and TGA Regulatory Signals – September/October 2026

Australia's Type 1 Diabetes Market: Device Demand, Reimbursement and TGA Regulatory Signals – September/October 2026

  • 2026-10-27 06:45:32

Australia's type 1 diabetes market presents opportunities for medical device companies, particularly in continuous glucose monitoring (CGM), as government subsidies support access to diabetes technologies. This article examines market growth, reimbursement arrangements and key Therapeutic Goods Administration (TGA) requirements, including Australian Register of Therapeutic Goods (ARTG) inclusion and unique device identification (UDI) compliance. It also explores opportunities across diabetes device categories and outlines practical considerations for companies planning to enter the Australian market.

More
QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

  • 2026-10-27 06:15:00

Qualtech's webinar on September 17, 2026 reviewed key regulatory developments for medical devices in Japan and South Korea. The Japan session covered how existing biocompatibility reports can support PMDA submissions, including JIS T 0993-1:2020 requirements, material documentation, GLP compliance and the acceptance of overseas test data. The South Korea session outlined the Digital Medical Products Act framework, covering device status determination, classification, regulatory pathways, K-GMP and post-market obligations.

More
QT Analysis: Taiwan TFDA Upgrades IVD Regulatory Requirements for CRP and AST Systems – How Should Companies Adjust Their Market Strategy? – September/October 2026

QT Analysis: Taiwan TFDA Upgrades IVD Regulatory Requirements for CRP and AST Systems – How Should Companies Adjust Their Market Strategy? – September/October 2026

  • 2026-10-27 05:30:31

Taiwan's Food and Drug Administration (TFDA) released new guidance in August and September 2026 for C-Reactive Protein (CRP) assays and Antimicrobial Susceptibility Testing (AST) systems, two Class II in vitro diagnostic (IVD) device categories. The updates require CRM470 calibration traceability and additional clinical data for hsCRP cardiovascular risk claims, as well as multi-center accuracy studies for AST systems. This analysis reviews the key changes, their impact on registration timelines and market competition, and the value of an early technical documentation gap analysis.

More